Endocrinology and Diabetes Center, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kouhoku-ku, Yokohama, Kanagawa, 222-0036, Japan.
Department of Epidemiology, UCLA Fielding School of Public Health, 650 Charles E. Young Dr. South, 16-035 Center for Health Sciences, Los Angeles, CA, USA.
J Med Case Rep. 2021 May 22;15(1):282. doi: 10.1186/s13256-021-02852-z.
Pheochromocytoma and paraganglioma caused by succinate dehydrogenase gene mutations is called hereditary pheochromocytoma/paraganglioma syndrome. In particular, succinate dehydrogenase subunit B mutations are important because they are strongly associated with the malignant behavior of pheochromocytoma and paraganglioma . This is a case report of a family of hereditary pheochromocytoma/paraganglioma syndrome carrying a novel mutation in succinate dehydrogenase subunit B.
A 19-year-old Japanese woman, whose father died of metastatic paraganglioma, was diagnosed with abdominal paraganglioma, and underwent total resection. Succinate dehydrogenase subunit B genetic testing detected a splice-site mutation, c.424-2delA, in her germline and paraganglioma tissue. Afterwards, the same succinate dehydrogenase subunit B mutation was detected in her father's paraganglioma tissues. In silico analysis predicted the mutation as "disease causing." She is under close follow-up, and no recurrence or metastasis has been observed for 4 years since surgery.
We detected a novel succinate dehydrogenase subunit B mutation, c.424-2delA, in a Japanese family afflicted with hereditary pheochromocytoma/paraganglioma syndrome and found the mutation to be responsible for hereditary pheochromocytoma/paraganglioma syndrome. This case emphasizes the importance of performing genetic testing for patients with pheochromocytoma and paraganglioma suspected of harboring the succinate dehydrogenase subunit B mutation (that is, metastatic, extra-adrenal, multiple, early onset, and family history of pheochromocytoma and paraganglioma) and offer surveillance screening to mutation carriers.
琥珀酸脱氢酶基因突变引起的嗜铬细胞瘤和副神经节瘤称为遗传性嗜铬细胞瘤/副神经节瘤综合征。特别是琥珀酸脱氢酶亚基 B 的突变很重要,因为它们与嗜铬细胞瘤和副神经节瘤的恶性行为密切相关。这是一个携带琥珀酸脱氢酶亚基 B 新突变的遗传性嗜铬细胞瘤/副神经节瘤综合征家族的病例报告。
一名 19 岁的日本女性,其父亲因转移性副神经节瘤去世,被诊断为腹部副神经节瘤,并接受了全切除手术。琥珀酸脱氢酶亚基 B 基因检测在其生殖系和副神经节瘤组织中发现了一个剪接位点突变,c.424-2delA。随后,在她父亲的副神经节瘤组织中也检测到了相同的琥珀酸脱氢酶亚基 B 突变。计算机模拟分析预测该突变“致病变异”。她正在密切随访中,自手术以来 4 年未观察到复发或转移。
我们在一个患有遗传性嗜铬细胞瘤/副神经节瘤综合征的日本家族中检测到一个新的琥珀酸脱氢酶亚基 B 突变 c.424-2delA,该突变导致遗传性嗜铬细胞瘤/副神经节瘤综合征。该病例强调了对疑似携带琥珀酸脱氢酶亚基 B 突变(即转移性、肾上腺外、多发性、早发和嗜铬细胞瘤和副神经节瘤家族史)的嗜铬细胞瘤和副神经节瘤患者进行基因检测的重要性,并为突变携带者提供了监测筛查。